Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06904313 · ClinicalTrials.gov registry record · Phase 2
Ultralow Dose PET Imaging for PSMA Expression
A Phase 2 study of Healthy Volunteer and Prostate CA, sponsored by Akiva Mintz.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06904313: Recruiting Phase 2 study of Healthy Volunteer and Prostate CA, sponsored by Akiva Mintz.
NCT06904313 is a Phase 2 study of Healthy Volunteer and Prostate CA that is actively recruiting participants, run by Akiva Mintz. The registered enrollment target is 200 participants, roughly in line with the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06904313, a Phase 2 study of Healthy Volunteer and Prostate CA, is actively recruiting participants, sponsored by Akiva Mintz.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for prostate cancer detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer called 18F-DCFPyL and be imaged on a new type of high sensitivity PET scanner for up to 3 hours
Primary Outcome
Measurement of signal-to-noise ratio for image quality assessment across different scan durations, reconstruction techniques, and AI-enhanced image reconstructions. Unit of Measure: SNR (unitless, numeric ratio)
Conditions Studied
Interventions
- DRUG Piflufolastat F18
Study Locations (1)
New Jersey
- Nuclear Imaging Institute - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-05-12 |
| Est. Completion | 2030-06-30 |
| Phase | Phase 2 |
What NCT06904313 shows while recruiting
NCT06904313 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target.
The record links to 2 conditions, with Healthy Volunteer appearing as the primary indexed condition, and to 1 intervention - of which Piflufolastat F18 is the first listed.
NCT06904313 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06904313 about?
NCT06904313 is a clinical study titled "Ultralow Dose PET Imaging for PSMA Expression". The goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for prostate cancer detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose...
What is the current status of trial NCT06904313?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2025-05-12. Estimated completion is 2030-06-30.
What conditions does trial NCT06904313 study?
This clinical trial studies the following conditions: Healthy Volunteer, Prostate CA.
What interventions are being tested in trial NCT06904313?
The interventions under investigation include: Piflufolastat F18 (DRUG).
Who is sponsoring clinical trial NCT06904313?
This trial is sponsored by Akiva Mintz, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06904313 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06904313's enrollment target sits among peer trials
200 15th of 112 higher than 94 of 112 other Healthy Volunteer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers
RECRUITING · Phase 2
-
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
RECRUITING · Phase 2
-
Ultralow Dose PET Imaging of 18F-FDG Uptake
RECRUITING · Phase 2
-
Ultralow Dose PET Imaging for 18F-NaF Uptake
RECRUITING · Phase 2
-
Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine
COMPLETED · Phase 2
-
Healthy Volunteer Study
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI